Business context and reporting period
Filing identity mismatch: The supplied filing is Gold Swap Inc.’s Form 10-K, not a filing for Silo Pharma, Inc. It covers the fiscal year ended December 31, 2011; the financial statements also compare with 2010 and provide inception-to-date figures from July 13, 2010.
Gold Swap described itself as a development-stage company planning a mail-order business to acquire consumers’ unwanted precious-metal jewelry and sell it to refineries. It had not commenced planned principal operations. Its two websites were not functioning, it had no refinery agreements, and it reported no employees other than its officers.
Financial performance and position
| Metric | 2011 | Prior comparable period |
|---|---|---|
| Revenue | $0 | $0 from inception through December 31, 2010 |
| Operating expenses / net loss | $49,803 | $1,078,505 from inception through December 31, 2010 |
| Net loss per share, basic and diluted | $0.00 loss per share as presented | $0.04 loss per share |
| Net cash used in operating activities | $46,303 | $3,505 from inception through December 31, 2010 |
| Cash at year-end | $1,752 | $47,480 |
| Accounts payable | $3,500 | $0 |
| Total assets | $1,752 | $47,480 |
| Stockholders’ equity (deficit) | $(1,748) | $47,480 |
For the year ended December 31, 2011, the company reported no revenue and a $49,803 net loss. The filing gives no meaningful operating margin because the business had not begun operations. The 2011 loss was substantially lower than the 2010 inception-period loss, primarily because 2010 included $1,075,000 of noncash compensation expense for shares issued to officers and directors. Cumulative net loss since inception was $1,128,308; cumulative operating cash use was $49,808.
The filing reports no borrowings or interest expense; year-end current liabilities consisted of $3,500 in accounts payable. Liquidity was limited to $1,752 of cash, and working capital was negative $1,748. No off-balance-sheet arrangements were reported. The auditors’ report included a going-concern paragraph, citing substantial doubt about the company’s ability to continue operating.
Material changes versus the prior period
- Cash fell from $47,480 at December 31, 2010 to $1,752 at December 31, 2011, while accounts payable rose to $3,500.
- Operating expenses and net loss declined to $49,803 from $1,078,505 in the prior inception period. The comparison is heavily affected by the one-time $1,075,000 stock-based compensation charge in 2010.
- The company remained pre-revenue and had not launched its planned business.
Outlook, risks and unusual items
Management estimated it needed at least $150,000 over the next 12 months for website work, marketing, security, insurance, legal and accounting costs. The company had no binding financing arrangement; officers and directors had orally indicated they might fund expenses, but were not legally obligated to lend. Management warned that failure to obtain funding could require curtailed development or leave the company dormant.
Management’s stated plan was to secure refinery and collection-agent agreements, complete customer-kit tracking and website systems, then begin marketing. These were plans, not firm guidance; the filing provided no revenue or profitability forecast. Management acknowledged that timing was uncertain and that the company had no current day-to-day operations.
- Key execution risks include lack of refinery relationships, nonfunctioning websites, limited operating history, minimal cash, and dependence on additional funding.
- The company said it did not currently have insurance; planned coverage of up to $500 per customer kit was conditional on obtaining insurance. Theft or loss in transit could cause losses and reputational damage.
- Other material risks include gold-price volatility, competition, consumer-protection and licensing requirements, and part-time management with no specific precious-metals recycling experience.
- The 2010 officer and director share awards generated $1,075,000 of compensation expense. Insiders held 70.18% of outstanding common stock, and the company lacked independent audit and compensation committees.
- The common stock was quoted on the OTCBB, but trading had only commenced January 6, 2012, and no OTCBB sales had occurred as of January 25, 2012. The company did not anticipate paying dividends.
Most important facts for investors to verify
- Confirm the filing belongs to Gold Swap Inc., not Silo Pharma, Inc., and verify the correct issuer and reporting period before relying on these figures.
- Verify the reported year-end cash, accounts payable, operating cash use, and the auditor’s going-concern warning against the audited statements.
- Determine whether the company subsequently raised the estimated $150,000 or obtained legally binding financing.
- Check whether refinery, collection-agent, insurance, website, and customer-tracking arrangements were actually completed and operations began.
- Review the terms and valuation of the 2010 insider share awards, insider voting control, and the liquidity and trading status of the stock.